Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel André

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Physical Review Letters|May 16, 2007
Universal approach to optimal photon storage in atomic mediaAlexey V Gorshkov, Axel André, Michael Fleischhauer, et al.
Hemasphere|July 31, 2024
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life studyAxel André, Lydia Montes, Damien Roos-Weil, et al.
Haematologica|April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA studyAxel André, Estelle Bourbon, Guillaume Cartron, et al.
Hemasphere|May 8, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA groupPierre Sesques, Guillaume Manson, Guillaume Cartron, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Physical Review Letters|May 16, 2007
Universal approach to optimal photon storage in atomic mediaAlexey V Gorshkov, Axel André, Michael Fleischhauer, et al.
Hemasphere|July 31, 2024
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life studyAxel André, Lydia Montes, Damien Roos-Weil, et al.
Haematologica|April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA studyAxel André, Estelle Bourbon, Guillaume Cartron, et al.
Hemasphere|May 8, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA groupPierre Sesques, Guillaume Manson, Guillaume Cartron, et al.
Pageof 1